NCT02552901View on ClinicalTrials.gov

Cardiox Liver Function Test Pivotal Trial

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Hepatic FailureLiver Failure
Interventions
DRUG

0.1 mg/kg ICG Dose

least efficacious dose

DRUG

0.5 mg/kg ICG dose

per package insert

Trial Locations (1)

43210

The Ohio State University Wexner Medical Center, Columbus

Sponsors
All Listed Sponsors
lead

Cardiox Corporation

INDUSTRY